Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases. [electronic resource]
- Arthritis research & therapy Feb 2016
- 49 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1478-6362
10.1186/s13075-016-0946-9 doi
Adult Aged Autoimmune Diseases--blood Female Humans Interferon-alpha--therapeutic use Interferon-beta--therapeutic use Lupus Erythematosus, Systemic--blood Male Middle Aged Multiple Sclerosis--blood Treatment Outcome